0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Effects of bronchoalveolar lavage on Mycoplasma Pneumoniae pneumonia: A propensity score matched-cohort study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The purpose of this study was to evaluate the efficacy and safety of BAL in treating MPP.

          Methods

          From January 2013 to January 2019, 1,689 pediatric patients with MPP were analyzed retrospectively. Patients were subdivided into BAL group and non-BAL group according to whether they received BAL treatment within seven days after admission. The propensity score matching method matched patients' baseline characteristics (1:1). The primary outcomes were hospital stays and the cure rate. Secondary outcomes included mortality, co-infection, repeat hospitalization within 30 days, and total cost of treatment.

          Results

          After matching, 524 patients (BAL: 262; control: 262) were recorded. The BAL group had significantly shorter hospital stays (OR: 0.5, 95% CI: 0.4–0.7). Meanwhile, BAL did not significantly modify the cost, co-infection rate, and mortality. In subgroup analyses, the group with BAL intervention within three days had a significantly shorter hospital stay (OR: 0.4, 95% CI: 0.3–0.5) compared with the group with BAL intervention three days after admission.

          Conclusions

          Early BAL intervention is a better treatment than conventional drug therapy alone, and no significant complications were seen in this study. BAL intervention has an excellent clinical benefit. The earlier the intervention, the better the effect.

          Related collections

          Most cited references41

          • Record: found
          • Abstract: found
          • Article: not found

          Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America

          Background: This document provides evidence-based clinical practice guidelines on the management of adult patients with community-acquired pneumonia. Methods: A multidisciplinary panel conducted pragmatic systematic reviews of the relevant research and applied Grading of Recommendations, Assessment, Development, and Evaluation methodology for clinical recommendations. Results: The panel addressed 16 specific areas for recommendations spanning questions of diagnostic testing, determination of site of care, selection of initial empiric antibiotic therapy, and subsequent management decisions. Although some recommendations remain unchanged from the 2007 guideline, the availability of results from new therapeutic trials and epidemiological investigations led to revised recommendations for empiric treatment strategies and additional management decisions. Conclusions: The panel formulated and provided the rationale for recommendations on selected diagnostic and treatment strategies for adult patients with community-acquired pneumonia.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Methylprednisolone pulse therapy for refractory Mycoplasma pneumoniae pneumonia in children

            Summary Objectives To determine the efficacy of methylprednisolone pulse therapy for children with Mycoplasma pneumoniae pneumonia (MP) that is refractory to antibiotic treatment. Methods Refractory patients were defined as cases showing clinical and radiological deterioration despite appropriate antibiotic therapy for 7 days or more. We identified 6 such children (male/female: 3/3) aged 3–9 years who were treated between 1998 and 2006. During the same period, 190 children with MP were admitted to our institution. Results Common laboratory findings of the patients included cytopenia, elevated serum lactate dehydrogenase and ferritin levels, and elevated urine β2-microglobulin levels, suggesting complication of hypercytokinemic condition. We initiated intravenous methylprednisolone at a dose of 30 mg/kg on 10.2 ± 2.8 clinical days and administered it once daily for 3 consecutive days. Fever subsided 4–14 h after initiation of steroid pulse therapy in all patients. This dramatic effect was accompanied by rapid improvement of radiological abnormalities including infiltrates and pleural effusion, followed by improvement of laboratory abnormalities. There were no adverse events of steroid therapy. Conclusions This is the first case-series study showing an effect of 3-day methylprednisolone pulse therapy on refractory MP in children. This therapy is apparently an efficacious and well-tolerated treatment for refractory MP.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Mycoplasma pneumoniae Among Children Hospitalized With Community-acquired Pneumonia

              The epidemiology of Mycoplasma pneumoniae (Mp) among US children (<18 years) hospitalized with community-acquired pneumonia (CAP) is poorly understood.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Pediatr
                Front Pediatr
                Front. Pediatr.
                Frontiers in Pediatrics
                Frontiers Media S.A.
                2296-2360
                04 January 2023
                2022
                : 10
                : 1066640
                Affiliations
                [ 1 ]Department of Pharmacy, National Children's Medical Center, Children's Hospital of Fudan University , Shanghai, China
                [ 2 ]Department of Respiratory Disease, National Children's Medical Center, Children's Hospital of Fudan University , Shanghai, China
                Author notes

                Edited by: Guanhua Xue, Children's Hospital of Capital Institute of Pediatrics, China

                Reviewed by: Yibing Cheng, Children's Hospital Affiliated of Zhengzhou University, China Xiaoxing You, University of South China, China

                [* ] Correspondence: Xiaobo Zhang zhangxiaobo0307@ 123456163.com Zhiping Li zpli@ 123456fudan.edu.cn

                Specialty Section: This article was submitted to Pediatric Infectious Diseases, a section of the journal Frontiers in Pediatrics

                Article
                10.3389/fped.2022.1066640
                9846808
                36683805
                e5df9934-bb7d-487d-9687-28927a9e0b8f
                © 2023 Lu, Zhang, Wang, Zhang and Li.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 11 October 2022
                : 12 December 2022
                Page count
                Figures: 2, Tables: 2, Equations: 0, References: 41, Pages: 0, Words: 0
                Funding
                Funded by: China-WHO Biennial Collaborative Projects
                Award ID: WPCHN1611348
                Funded by: National Natural Science Foundation
                Award ID: 81874325
                Categories
                Pediatrics
                Original Research

                mycoplasma,pneumonia,medication,bronchoalveolar lavage,child,infection

                Comments

                Comment on this article